Ready to build your own Founder-Led Growth engine? Book a Strategy Call
Frontlines.io | Where B2B Founders Talk GTM.
Strategic Communications Advisory For Visionary Founders
Kevin's partnership with Professor Harris Wong showcases the power of combining expertise from different domains — operational skills with scientific knowledge. For founders, especially in fields as complex as biotech, finding a co-founder with complementary skills can accelerate your startup's development and help navigate the unique challenges of your industry.
Aclid's approach to automating biosecurity processes demonstrates the importance of leveraging technology to solve critical industry pain points. Founders should focus on identifying these pain points through extensive research and conversations within their target industry and then use technology to develop innovative solutions that address these challenges effectively.
Starting with early-stage manufacturers allowed Aclid to enter the market with a solution that addressed a clear need, and then scale based on feedback and the development of their product. This iterative approach, starting small and growing with your user base, can be crucial for startups looking to make a significant impact in established industries.
As Aclid navigates the emerging biosecurity regulatory landscape, Kevin's proactive involvement in policy discussions underscores the value of engaging with regulatory processes and contributing to thought leadership in your sector. Founders should consider how regulations might affect their industry and get involved early to help shape policies that support innovation while ensuring safety and compliance.
Aclid's marketing philosophy focuses on offering technical, useful resources to build trust and establish thought leadership. This approach can be particularly effective in complex industries where clients value deep insights and solutions to intricate problems. Startups should consider developing content that not only highlights their product but also provides valuable industry knowledge and support.
Building the Security Layer for Synthetic Biology: How Aclid is Defining a New Category
The parallels between the early days of the internet and synthetic biology are striking. Both represent transformative technologies that began with minimal security guardrails. But while the internet’s security infrastructure evolved reactively, often in response to breaches and attacks, synthetic biology presents an opportunity to build security from the ground up.
In a recent episode of Category Visionaries, Kevin Flyangolts shared how Aclid is working to become the security layer for synthetic biology—an industry where a single breach could have catastrophic consequences.
Finding Product-Market Fit in a Nascent Market
When Kevin and his co-founder Professor Harris Wong started Aclid, they spent their first three months doing what many founders neglect: talking to potential customers. “We spent probably the first three months talking to 40 to 60 different manufacturers and just learning, figuring out what it is that they do day to day. Where are the biggest pain points? Is it in the screening? Is it in the vetting of the customer? Is it somewhere totally else?”
This deep customer discovery process revealed a counterintuitive insight. While large manufacturers had already built internal systems for biosecurity compliance, early-stage manufacturers were struggling with manual processes and limited resources. Instead of targeting the biggest players, Aclid found its initial foothold with smaller companies where the pain point was most acute.
“When you’re an early stage company, you are dealing with a lot of problems,” Kevin explains. “If you’re starting a company that requires facilities, 50 people, just to get started, just to build your first product and sell it to a customer, there’s just that much more. And dealing with compliance burdens along that way makes it that much harder.”
Building Trust Through Technical Authority
For any security-focused startup, establishing trust is paramount. Aclid’s approach to building credibility mirrors successful strategies from the cybersecurity industry. “I personally really like what the cybersecurity space has done in marketing, where they offer you technical resources on SoC two compliance, ISO compliance, on x vulnerability or y exploit, and those technical resource end up helping you build trust with that company.”
This content-driven approach positions Aclid as a thought leader while creating a natural path to customer conversations. Rather than pushing sales messages, they focus on building resources that help manufacturers navigate complex compliance requirements.
Shaping Regulation as a Competitive Moat
While many startups view regulation as an obstacle, Aclid is actively helping shape the regulatory landscape. “We’re working with both policymakers and industry, academia as well as politicians directly to make sure that our voice is heard and the right technical implementation is made,” Kevin notes.
This proactive engagement with policy puts Aclid in a unique position as new regulations emerge. Two bills are currently moving through Congress, and an executive order on AI has expanded to include biosecurity concerns. By participating in these discussions, Aclid ensures that upcoming regulations are both effective and implementable.
The Evolution of Go-to-Market Strategy
As Aclid has grown, their go-to-market strategy has evolved from focusing solely on early adopters to working with some of the industry’s largest manufacturers. This expansion required careful positioning of their value proposition. Instead of competing with existing in-house systems, they focus on automation and efficiency: “making them more automated, and giving them their ability to focus back on the chemistry and the manufacturing, rather than on the administrative burden of compliance.”
Building Infrastructure for the Future
Kevin’s vision extends beyond immediate compliance needs. “What I really want to see in the next five to ten years is us be the security and safety layer for this industry. Helping build the infrastructure that helps scientists get access to the tools and the products that they need with as little as possible hurdles.”
This infrastructure-first mindset draws parallels to the financial industry: “Like what you have in finance, there’s a whole bunch of things that happen every time a transaction goes through, every time you swipe a credit card, every time you send a wire a whole bunch of checks to make sure that there’s no fraud. We want to help build that for synthetic biology.”
This approach of building foundational infrastructure rather than just point solutions positions Aclid to become an essential player as synthetic biology matures. By focusing on automation and scalability from the start, they’re creating systems that can grow with the industry while maintaining the security guardrails necessary for responsible innovation.
The synthetic biology industry stands at a crucial junction. As capabilities expand and access becomes more democratized, the need for robust security infrastructure becomes increasingly critical. Aclid’s journey offers valuable lessons for founders building in regulated markets: focus on acute pain points, build trust through expertise, and don’t shy away from helping shape the regulatory landscape.
CEO and Founder of Amenities Health
Aasim Saeed, CEO and Founder of Amenities Health: $10 Million Raised to Build the Future of Patient Engagement
CEO of DermaSensor
Cody Simmons, CEO of DermaSensor: $36 Million Raised to Build the First AI-Powered Skin Cancer Detection Tool for Primary Care
Co-Founder and CEO of Inato
Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials
Marketing & Sales Enablement Lead of FIGUR8
Integrity-Driven Marketing: FIGUR8’s Path to 3,000+ Clinics
CEO of Identifeye Health
Vicky Demas, CEO of identifeye HEALTH: $90 Million Raised to Power the Future of Retinal Imaging
VP of Marketing of Healthee
Why AI Should Enhance, Not Replace Your Marketing Team
Founder & CMO of Savana
Ignacio Medrano, Founder & CMO of Savana: $44M Raised to Transform Healthcare Intelligence Through AI
CEO and Co-Founder of DignifiHealth
Richard Queen, CEO and Co-Founder of DignifiHealth: $7 Million Raised to Drive Better Patient Outcomes in Rural Healthcare and Beyond
CEO of SocialClimb
Ty Allen, CEO of SocialClimb: $12 Million Raised to Power the Future of Healthcare Marketing
Founder and CEO of Radish Health
Viral Patel, CEO of Radish Health: $5 Million Raised to Connect Employees with a Better Healthcare Experience
CEO and Founder of Valo
David Berry, CEO and Founder of Valo: Over $500 Million Raised to Build the Future of Drug Discovery
Senior Vice President of Marketing and Communications of Capital Rx
How to Build 18-Month Attribution Models That Actually Work
CEO and Co-Founder of Sorcero
Dipanwita Das, CEO and Co-Founder of Sorcero: Over $20 Million Raised to Power Medical Affairs Teams of the Future
CEO and Co-Founder of Thoughtful AI
Alex Zekoff, CEO and Co-Founder of Thoughtful AI: $21 Million Raised to Power the Future of Healthcare Automation
CEO & Founder of Delfina
Senan Ebrahim, CEO & Founder of Delfina: $10 Million Raised to Build the Future of Intelligent Pregnancy Care
CEO and Co-Founder of Venteur
Stacy Edgar, CEO & Co-Founder of Venteur: $7.6 Million Raised to Build the Future of Health Insurance
CEO & Founder of Ansel Health
Veer Gidwaney, CEO & Founder of Ansel Health: $50 Million Raised to Transform Supplemental Health Insurance
Founder and CEO of Trial Library
Hala Borno, Founder and CEO of Trial Library: $5M Raised to Improve Patient Recruitment and Diversity in Oncology Clinical Trials
CEO of Datacubed Health
Brett Kleger, CEO of Datacubed Health: $43 Million Raised to Revolutionize Clinical Trial Data Collection
CEO of Trek Health
Dilpreet Sahota, CEO of Trek Health: $3 Million Raised to Help Mental Health Providers Accept Insurance
CEO & Co-Founder of Synthpop
Elad Ferber, CEO & Co-Founder of Synthpop: $8 Million Raised to Build the Future of Healthcare Administration with AI
CEO and Founder of FIGUR8
Dr. Nan-Wei Gong, CEO & Founder of FIGUR8: $40 Million Raised to Build the Future of Musculoskeletal Health and Injury Data Solutions
CEO and Co-Founder of Yuvo Health
Cesar Herrera, CEO and Co-Founder of Yuvo Health: $28 Million Raised to Revolutionize Healthcare Access
Founder and CEO of Phamily
How Phamily built an eight-figure ARR healthcare company without discounting: The subsidized R&D approach | Nabeel Kaukab ($25M Raised)
CEO of Arrive Health
Kyle Kiser, CEO of Arrive Health: Over $40 Million Raised to Improve the Value of Healthcare Through Informed Decision-Making
CEO & Founder of Decent
Nick Soman, CEO & Founder of Decent: $43 Million Raised to Build the Future of Direct Primary Care
CEO & Founder of Portal
Armon Sharei, CEO & Founder of Portal: $5 Million Raised to Power the Future of Cell Engineering
CEO and Founder of Authenticx
Amy Brown, CEO and Founder of Authenticx: $28 Million Raised to Build the Future of Listening AI
CEO of PathologyWatch
Daniel Lambert, CEO of PathologyWatch: Over $50 Million Raised to Build the Future of Digital Pathology
CEO and Co-Founder of Corti
Andreas Cleve, CEO and Co-Founder of Corti: $32 Million Raised to Power the Future of Patient Consultations
CEO & Founder of Epitel
Mark Lehmkuhle, CEO & Founder of Epitel: $20 Million Raised to Build the Future of Brain Health Monitoring
Founder & CEO of Praia Health
Justin Dearborn, Founder & CEO of Praia Health: $20 Million Raised to Build the Future of Consumer Experience in Healthcare
Head of Marketing of Intelligencia AI
Beyond Perfect: Healthcare Tech Marketing That Drives Real Revenue
CEO & Founder of VitVio
Thomas Knox, CEO & Founder of VitVio: $10 Million Raised to Transform Surgical Operations Through AI-Powered Automation
Director of Growth of Nelly Solutions
How Nelly Grew 3X Through Meta Ads in Health Tech
CEO and Founder of AppliedVR
Matthew Stoudt, CEO and Founder of AppliedVR: Over $70 Million Raised to Build the Future of Chronic Pain Relief
CEO & Co-Founder of Upfront Healthcare
Ben Albert, CEO & Co-Founder of Upfront Healthcare: $30 Million Raised to Power the Future of Patient Engagement
CEO and Co-Founder of PocketHealth
Rishi Nayyar, CEO and Co-Founder of PocketHealth: $22.5 Million Raised to Power the Future of Medical Image Sharing
CEO & Co-Founder of Uptiv Health
Torben Nielsen, CEO of Uptiv Health: $7.5M Raised to Build the Future of Infusion Therapy Through Technology-Enabled Retail Centers
CEO & Founder of Canary Speech
Henry O’Connell, CEO & Founder of Canary Speech: $26 Million Raised to Build the Future of Vocal Biomarker Technology
Founder of Torch Dental
Khaled Boukadoum, Founder of Torch Dental: $49.5 Million Raised to Transform Dental Supply Management Through Digital Innovation
CEO and Co-Founder of Socially Determined
Trenor Williams, CEO and Co-Founder of Socially Determined: $34 Million Raised to Build the Social Risk Intelligence Category
CEO & Co-Founder of Prescribe FIT
Brock Leonti, CEO & Co-Founder of Prescribe FIT: $15 Million Raised to Build the Future of Orthopedic Care
Founder of GigXR
David King Lassman, Founder of GigXR: $7 Million Raised to Bring Immersive Learning to Healthcare
Senior Marketing Manager of Amenities Health
Humanizing Healthcare Tech: Marketing Lessons from Amenities
CEO & Co-Founder of Siftwell Analytics
Trey Sutten, CEO & Co-Founder of Siftwell Analytics: $5 Million Raised to Transform Healthcare Analytics with AI-Powered Predictions
President and Founder of Narrativa
How Narrativa leveraged COVID-19 as a market catalyst to accelerate AI adoption in pharma | Jennifer Bittinger ($2.4M Raised)
CEO and Co-Founder of Zivian Health
Rafid Fadul, CEO and Co-Founder of Zivian Health: $3 Million Raised to Power the Future of Compliant Healthcare Collaborations
President and Co-Founder of Homeward
Amar Kendale, President & Co-Founder of Homeward: $70 Million Raised to Transform Rural Healthcare Through Technology
CEO & Co-Founder of StretchDollar
How StretchDollar drives leads from LLM search | Marshall Darr
Co-Founder & CEO of Lynx
Matt Renfro, CEO of Lynx: $17.5 Million raised to Bring Modern Fintech to Healthcare
CEO & Founder of Blueprint
Danny Freed, CEO & Founder of Blueprint: $13.7 Million Raised to Build the Future of Therapist Enablement
Co-Founder and CEO of PayZen
Itzik Cohen, Co-Founder and CEO of PayZen: $240 Million Raised to Build the Future of Affordable Health Care
CEO of 1upHealth
Joe Gagnon, CEO at 1upHealth: Over $75 Million Raised to Build the Future of Healthcare Data
CEO of Casana
Austin McChord, CEO of Casana: Over $46 Million Raised to Create the Future of In-Home Health Monitoring
Founder of Teladoc
Teladoc Founder Michael Gorton on the Early Days of Pioneering the Telemedicine Category (And What’s He’s Up to Next)
Founder of Akston Biosciences
Todd Zion, Founder of Akston Biosciences: From a $500M Exit to Pioneering Biotech Innovation in Pet Health
Co-Founder and CEO of HealthSnap
Samson Magid, Co-Founder and CEO of HealthSnap: Over $12 Million Raised to Build the Future of Remote Patient Monitoring
Mastering Market Fit in AI: Insights from Michael Chang, Director of Marketing at ArteraAI
CEO and Co-Founder of CEO and Co-Founder
Alfred Griffin, CEO and Co-Founder of LightForce: $150 Million Raised to Power the Future of Orthodontics
Co-Founder & Chief Executive Officer of Dexcare
Derek Streat, CEO of Dexcare: $110 Million Raised to Help Health Systems to Find Time for the Best Care
CEO and Co-Founder of Gradient Health
Joshua Miller, CEO & Co-Founder of Gradient Health: $5.7 Million Raised to Build the Future of Medical Imaging
CEO of Prospection
Daniel West, CEO of Prospection: $36 Million Raised to Build the Future of Patient-Centric Intelligence
CEO and Founder of AdviNOW Medical
James Bates, CEO and Founder of AdviNOW Medical: $24 Million Raised to Build the Future of AI-Powered Healthcare
CEO & Co-Founder of Brightside
Brad Kittredge, CEO & Co-Founder of Brightside: $150 Million Raised to Build the Future of Mental Healthcare
CEO & Founder of B.well
Kristen Valdes, CEO & Founder of B.well: $100 Million Raised to Reimagine the Healthcare Experience
CEO of Trusty Care
Joseph Schneier, CEO of Trusty Care: $13+ Million Raised to Shape the Future of Medicare
CEO & Co-Founder of Intelligencia AI
Dimitrios Skaltsas, CEO & Co-Founder of Intelligencia AI: $15.5 Million Raised to Build the Future of Drug Development
CEO of Anomaly
Why Anomaly avoids annual curiosity revenue (ACR) — and you probably should to | Mike Desjadon ($30M Raised)
CEO of Feedback PLC
Dr Thomas Oakley, CEO of Feedback PLC: £20 Million Raised to Build the Future of Patient Data Sharing